| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2020 | A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients | Wang Y.-H.; Lin C.-C.; Yao C.-Y.; Hsu C.-L.; Hou H.-A.; CHENG-HONG TSAI ; Chou W.-C.; Tien H.-F. | Blood Advances | 1 | ||
| 2019 | Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study | Liu J.-H.; Liao X.-W.; Chen C.-H.; Yao M.; Li C.-C.; Lin C.-T.; CHENG-HONG TSAI ; Chou W.-C.; Hou H.-A.; Huang S.-Y.; Wu S.-J.; Chen Y.-C.; Tien H.-F.; Tang J.-L.; Ko B.-S. | British Journal of Haematology | 1 | ||
| 2020 | ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden | Wang Y.-H.; Lin C.-C.; Lee S.-H.; CHENG-HONG TSAI ; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; Chou W.-C.; Tang J.-L.; Tien H.-F. | Blood Cancer Journal | 0 | ||
| 2019 | Brentuximab vedotin as a salvage treatment for relapsed and refractory Hodgkin lymphoma patients in Taiwan | Tien F.-M.; CHENG-HONG TSAI ; Liu J.-H.; Lin C.-T. | Journal of the Formosan Medical Association | 0 | ||
| 2012 | Bubbles in the urinary bladder | CHENG-HONG TSAI ; Yang F.-J.; Huang C.-C.; Kuo C.-C.; Chen Y.-M. | Netherlands Journal of Medicine | 0 | ||
| 2020 | A child with juvenile myelomonocytic leukemia possessing a concurrent germline CBL mutation and a NF1 variant of uncertain significance: A rare case with a common problem in the era of high-throughput sequencing | Wang W.-H.; Lu M.-Y.; CHENG-HONG TSAI ; Wang S.-C.; Chou S.-W.; Jou S.-T. | Journal of the Formosan Medical Association | 0 | ||
| 2018 | Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome | Ko B.-S.; Wang Y.-F.; Li J.-L.; Li C.-C.; Weng P.-F.; Hsu S.-C.; Hou H.-A.; Huang H.-H.; Yao M.; Lin C.-T.; Liu J.-H.; CHENG-HONG TSAI ; Huang T.-C.; Wu S.-J.; Huang S.-Y.; Chou W.-C.; Tien H.-F.; Lee C.-C.; Tang J.-L. | EBioMedicine | 13 | ||
| 2017 | Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia | Hou H.-A.; Lu J.-W.; Lin T.-Y.; CHENG-HONG TSAI ; Chou W.-C.; Lin C.-C.; Kuo Y.-Y.; Liu C.-Y.; Tseng M.-H.; Chiang Y.-C.; Peng Y.-L.; Tang J.-L.; Gong Z.; Lin L.-I.; Tien H.-F. | Blood cancer journal | 2 | ||
| 2018 | Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA | Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; CHENG-HONG TSAI ; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. | Haematologica | 2 | ||
| 2020 | Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax | Wang Y.-W.; CHENG-HONG TSAI ; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F. | Annals of Hematology | 6 | ||
| 2018 | Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome | Lin M.-E.; Hou H.-A.; CHENG-HONG TSAI ; Wu S.-J.; Kuo Y.-Y.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Chou W.-C.; Chen C.-Y.; Tang J.-L.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Lin C.-T.; Tien H.-F. | Clinical Epigenetics | 13 | ||
| 2018 | GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia | Tien F.-M.; Hou H.-A.; CHENG-HONG TSAI ; Tang J.-L.; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Lin C.-T.; Wu S.-J.; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Yao M.; Chou W.-C.; Tien H.-F. | Blood Cancer Journal | 11 | ||
| 2016 | Genetic alterations and their clinical implications in older patients with acute myeloid leukemia | CHENG-HONG TSAI ; Hou H.-A.; Tang J.-L.; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Kuo Y.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Tsay W.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tien H.-F. | Leukemia | 56 | ||
| 2018 | Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients | Tien F.-M.; Hou H.-A.; CHENG-HONG TSAI ; Tang J.-L.; Chen C.-Y.; Kuo Y.-Y.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. | European Journal of Haematology | 10 | ||
| 2019 | Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients | CHENG-HONG TSAI ; Yao C.-Y.; Tien F.-M.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Tien H.-F. | EBioMedicine | 9 | ||
| 2018 | Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome | Hou H.-A.; CHENG-HONG TSAI ; Lin C.-C.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Yao M.; Tang J.-L.; Tien H.-F. | Blood Cancer Journal | 28 | ||
| 2018 | Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information | Tefferi A.; Gangat N.; Mudireddy M.; Lasho T.L.; Finke C.; Begna K.H.; Elliott M.A.; Al-Kali A.; Litzow M.R.; Hook C.C.; Wolanskyj A.P.; Hogan W.J.; Patnaik M.M.; Pardanani A.; Zblewski D.L.; He R.; Viswanatha D.; Hanson C.A.; Ketterling R.P.; Tang J.-L.; Chou W.-C.; Lin C.-C.; CHENG-HONG TSAI ; Tien H.-F.; Hou H.-A. | Mayo Clinic Proceedings | 11 | ||
| 2018 | Outcome of acute leukemia patients with central nervous system (CNS) involvement treated with total body or CNS irradiation before transplantation | Kuo, Wen-Han; Chen, Yu-Hsuan; CHENG-HONG TSAI ; Liao, Xiu-Wen; Kuo, Sung-Hsin; Tang, Jih-Luh | Therapeutic Radiology and Oncology | 0 | ||
| 2017 | Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia | CHENG-HONG TSAI ; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Liu C.-Y.; Tseng M.-H.; Lin T.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Lin C.-T.; Wu S.-J.; Chen C.-Y.; Tsay W.; Chuang E.Y.; Chou W.-C.; Tien H.-F. | Blood Cancer Journal | 15 | ||
| 2018 | The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome | Yang Y.-T.; Chiu Y.-C.; Kao C.-J.; Hou H.-A.; Lin C.-C.; CHENG-HONG TSAI ; Tseng M.-H.; Chou W.-C.; Tien H.-F. | Blood Cancer Journal | 9 |
